Publications
- Disease Activity Is an Important Factor for Indeterminate Interferon-gamma Release Assay Results in Children With Inflammatory Bowel Disease2014 | Second Faculty of Medicine
- Predictive value of tissue calprotectin for disease recurrence after ileocecal resection in pediatric Crohn's disease2022 | Second Faculty of Medicine, Third Faculty of Medicine
- Adalimumab versus infliximab in pediatric patients with Crohn's disease: A propensity-score analysis and predictors of treatment escalation2022 | Second Faculty of Medicine
- Dificlir - fidaxomicin - an effective treatment option for C. difficile infections in children2022 | Second Faculty of Medicine
- Is It Useful to Monitor Thiopurine Metabolites in Pediatric Patients with Crohn's Disease on Combination Therapy? A Multicenter Prospective Observational Study2021 | First Faculty of Medicine, Second Faculty of Medicine
- Risk factors for dermatological complications of anti-TNF therapy in a cohort of children with Crohn's disease2021 | Second Faculty of Medicine
- Pediatric gastroenterology and hepatology2020 | Second Faculty of Medicine
- Safety of Anti-TNF-Alpha Therapy During Pregnancy on Longterm Outcome of Exposed Children: A Controlled, Multicenter Observation2019 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University
- Impact of anti-TNFα exposure in utero on the development of immune systems of exposed children - A controlled, multicentre observational study2018 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen
- Fecal calprotectin is not a clinically useful marker for the prediction of the early nonresponse to exclusive enteral nutrition in pediatric patients with Crohn disease2018 | Second Faculty of Medicine
Loading network view...